Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for June 15th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 15th:
AsburyAutomotive Group, Inc. (ABG - Free Report) : This automotive retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 3.9% over the last 60 days.
Asbury Automotive Group, Inc. Price and Consensus
Asbury Automotive Group, Inc. price-consensus-chart | Asbury Automotive Group, Inc. Quote
Asbury’s shares gained 4.3% over the last one month more than S&P 500’s gain of 1.8%. The company possesses a Momentum Score of B.
Asbury Automotive Group, Inc. Price
Asbury Automotive Group, Inc. price | Asbury Automotive Group, Inc. Quote
ABIOMED, Inc. : This developer and seller has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 8.4% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED, Inc. price-consensus-chart | ABIOMED, Inc. Quote
Anadarko Petroleum’s shares gained 15.6% over the last one month. The company possesses a Momentum Score of B.
ABIOMED, Inc. Price
ABIOMED, Inc. price | ABIOMED, Inc. Quote
AcelRx Pharmaceuticals, Inc. : This operator of a specialty pharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. price-consensus-chart | AcelRx Pharmaceuticals, Inc. Quote
Altair’s shares gained 40.2% over the last one month. The company possesses a Momentum Score of B.
AcelRx Pharmaceuticals, Inc. Price
AcelRx Pharmaceuticals, Inc. price | AcelRx Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>